{
    "nctId": "NCT01367639",
    "briefTitle": "Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers",
    "officialTitle": "Pilot Randomized Controlled Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers",
    "overallStatus": "COMPLETED",
    "conditions": "Hereditary Breast and Ovarian Cancer Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 67,
    "primaryOutcomeMeasure": "global psychology functioning(GSI)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women who are carriers of one of the predominant Jewish mutations in BRCA1/2 genes, age 35 years or older, with no current or past history of cancer (except BCC), who are willing to sign an informed consent, and present mental clarity by the ability to comprehend and fulfill all the questionnaires.\n\nExclusion Criteria:\n\n* Diagnosed with breast or ovarian cancer or any other cancer, self reported Pregnancy, risk reduction mastectomy, severe psychiatric diagnosis (e.g. bipolar disorder).",
    "sex": "FEMALE",
    "minimumAge": "35 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}